
Di Xiao
Examiner (ID: 13777, Phone: (571)270-1758 , Office: P/2141 )
| Most Active Art Unit | 2141 |
| Art Unit(s) | 2179, 2175, 2178, 2141 |
| Total Applications | 667 |
| Issued Applications | 485 |
| Pending Applications | 71 |
| Abandoned Applications | 138 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18012126
[patent_doc_number] => 11504400
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Method of treating meningioma
[patent_app_type] => utility
[patent_app_number] => 16/952116
[patent_app_country] => US
[patent_app_date] => 2020-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4628
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16952116
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/952116 | Method of treating meningioma | Nov 18, 2020 | Issued |
Array
(
[id] => 16837897
[patent_doc_number] => 20210145909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => Compositions and Methods for Treating the Eye
[patent_app_type] => utility
[patent_app_number] => 17/099185
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17099185
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/099185 | Compositions and methods for treating the eye | Nov 15, 2020 | Issued |
Array
(
[id] => 16837904
[patent_doc_number] => 20210145916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => Compositions and Methods for Treating the Eye
[patent_app_type] => utility
[patent_app_number] => 17/099166
[patent_app_country] => US
[patent_app_date] => 2020-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17099166
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/099166 | Compositions and methods for treating the eye | Nov 15, 2020 | Issued |
Array
(
[id] => 17006984
[patent_doc_number] => 20210238145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => DIARYLHYDANTOIN COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/088148
[patent_app_country] => US
[patent_app_date] => 2020-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33033
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17088148
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/088148 | DIARYLHYDANTOIN COMPOUNDS | Nov 2, 2020 | Abandoned |
Array
(
[id] => 17648508
[patent_doc_number] => 11351211
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-06-07
[patent_title] => Therapeutic composition comprising botanical extracts
[patent_app_type] => utility
[patent_app_number] => 17/027377
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 392
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17027377
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/027377 | Therapeutic composition comprising botanical extracts | Sep 20, 2020 | Issued |
Array
(
[id] => 17005418
[patent_doc_number] => 20210236579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => THERAPEUTIC USE OF CHARDONNAY SEED PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/020533
[patent_app_country] => US
[patent_app_date] => 2020-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10852
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17020533
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/020533 | Therapeutic use of chardonnay seed products | Sep 13, 2020 | Issued |
Array
(
[id] => 16686628
[patent_doc_number] => 20210069103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => ORAL CANNABINOID COMPOSITIONS AND METHODS FOR TREATING NEUROPATHIC PAIN
[patent_app_type] => utility
[patent_app_number] => 17/012366
[patent_app_country] => US
[patent_app_date] => 2020-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8846
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012366
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/012366 | Oral cannabinoid compositions and methods for treating neuropathic pain | Sep 3, 2020 | Issued |
Array
(
[id] => 18202331
[patent_doc_number] => 11584713
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => 25-hydroxycholecalciferol monohydrate crystal, preparation method therefor and microemulsion using same
[patent_app_type] => utility
[patent_app_number] => 16/986592
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4610
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16986592
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/986592 | 25-hydroxycholecalciferol monohydrate crystal, preparation method therefor and microemulsion using same | Aug 5, 2020 | Issued |
Array
(
[id] => 17821440
[patent_doc_number] => 11426363
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Compositions including cannabis and avocado/soybean unsaponifiables and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/930513
[patent_app_country] => US
[patent_app_date] => 2020-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5985
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16930513
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/930513 | Compositions including cannabis and avocado/soybean unsaponifiables and methods of use | Jul 15, 2020 | Issued |
Array
(
[id] => 16389598
[patent_doc_number] => 20200330539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => COMPOSITIONS CONTAINING SILYMARIN AND SULFOALKYL ETHER CYCLODEXTRIN AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/920127
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16920127
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/920127 | Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same | Jul 1, 2020 | Issued |
Array
(
[id] => 16581469
[patent_doc_number] => 20210015871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-21
[patent_title] => PROLINE-RICH POLYPEPTIDE COMPLEX FOR USE IN TREATMENT OF BDNF-DEPENDENT DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/917814
[patent_app_country] => US
[patent_app_date] => 2020-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16917814
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/917814 | Proline-rich polypeptide complex for use in treatment of BDNF-dependent disorders | Jun 29, 2020 | Issued |
Array
(
[id] => 16375044
[patent_doc_number] => 20200323886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => WOUND CARE FORMULATIONS WITH CLINICALLY EFFECTIVE INGREDIENT CONTENT
[patent_app_type] => utility
[patent_app_number] => 16/915837
[patent_app_country] => US
[patent_app_date] => 2020-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4571
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16915837
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/915837 | WOUND CARE FORMULATIONS WITH CLINICALLY EFFECTIVE INGREDIENT CONTENT | Jun 28, 2020 | Abandoned |
Array
(
[id] => 16374926
[patent_doc_number] => 20200323768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => LYOPHILIZED FORMULATION OF STEM CELL-DERIVED EXOSOMES AND ANTI-INFLAMMATORY COMPOSITION INCLUDING THE SAME AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 16/913624
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6500
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16913624
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/913624 | Lyophilized formulation of stem cell-derived exosomes and anti-inflammatory composition including the same as active ingredient | Jun 25, 2020 | Issued |
Array
(
[id] => 16726505
[patent_doc_number] => 20210093652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => COMPOSITIONS AND METHODS OF POTENTIATING ANTIMICROBIALS
[patent_app_type] => utility
[patent_app_number] => 16/896701
[patent_app_country] => US
[patent_app_date] => 2020-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16896701
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/896701 | Compositions and methods of potentiating antimicrobials | Jun 8, 2020 | Issued |
Array
(
[id] => 16799043
[patent_doc_number] => 10993958
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-05-04
[patent_title] => Aldehyde functional monoterpenoids for the treatment of coronavirus infection
[patent_app_type] => utility
[patent_app_number] => 16/882130
[patent_app_country] => US
[patent_app_date] => 2020-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14909
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16882130
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/882130 | Aldehyde functional monoterpenoids for the treatment of coronavirus infection | May 21, 2020 | Issued |
Array
(
[id] => 16762288
[patent_doc_number] => 20210107869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => Urea Derivative Or Pharmacologically Acceptable Salt Thereof
[patent_app_type] => utility
[patent_app_number] => 16/880443
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16880443
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/880443 | Urea derivative or pharmacologically acceptable salt thereof | May 20, 2020 | Issued |
Array
(
[id] => 16283724
[patent_doc_number] => 20200277326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => ARAMCHOL SALTS
[patent_app_type] => utility
[patent_app_number] => 16/874047
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16874047
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/874047 | ARAMCHOL SALTS | May 13, 2020 | Abandoned |
Array
(
[id] => 16238561
[patent_doc_number] => 20200255795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => METHOD FOR PREPARING MICROBIAL PREPARATION AND MICROBIAL PREPARATION PRODUCED BY THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/858640
[patent_app_country] => US
[patent_app_date] => 2020-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16858640
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/858640 | METHOD FOR PREPARING MICROBIAL PREPARATION AND MICROBIAL PREPARATION PRODUCED BY THE SAME | Apr 25, 2020 | Abandoned |
Array
(
[id] => 18185862
[patent_doc_number] => 11576413
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-14
[patent_title] => Compositions comprising ionized cannabidiol
[patent_app_type] => utility
[patent_app_number] => 16/839997
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3034
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16839997
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/839997 | Compositions comprising ionized cannabidiol | Apr 2, 2020 | Issued |
Array
(
[id] => 16175517
[patent_doc_number] => 20200222485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => MEDICINAL AMBROSIA PLANT EXTRACTS
[patent_app_type] => utility
[patent_app_number] => 16/829577
[patent_app_country] => US
[patent_app_date] => 2020-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16829577
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/829577 | MEDICINAL AMBROSIA PLANT EXTRACTS | Mar 24, 2020 | Abandoned |